The study has shown correlation between pulse rate and identification of a woman's fertile window; the company also announced new updates for its mobile app.
The study will use WebMD's newly redesigned Pregnancy app for iPhone, enabling participants to easily answer questions and share connected device data.
The app has been certified by the UK's Medicines and Healthcare products Regulatory Agency, which appointed Germany-based Tüv Süd to perform the inspection.
The iOS app allows users to track period of their cycle, including flow, symptoms, activities, and moods. Also, tracking is available for birth control.
The app's algorithm combines the gestation of previous pregnancies and the length of the cervix with levels of fetal fibronectin to classify a woman's risk.
The kit includes a device that works with a companion app to provide women with personalized content and information throughout the pregnancy.
The application provides women with real-time, personalized nutrition advice including meal recommendations and 24/7 nutritional support.
Developed in cooperation with OMRON, the device tracks a woman's cycle based on basal temperature readings and predicts ovulation to help couples conceive.
Ava's sensor bracelet is designed to be worn at night, offering key cycle health information that precisely predict fertile days and ovulation in advance.
Called Due Date Plus, the data-driven program identifies high-risk complications and drives appropriate actions; it currently covers over two million lives.